<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2021.12833</article-id>
<article-id pub-id-type="publisher-id">OL-0-0-12833</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MicroRNA-423-3p promotes glioma growth by targeting PANX2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jing</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>He</surname><given-names>Jian</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>He</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Peng</surname><given-names>Renjun</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Xi</surname><given-names>Jian</given-names></name></contrib>
</contrib-group>
<pub-date pub-type="ppub">
<month>08</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>06</month>
<year>2021</year></pub-date>
<volume>22</volume>
<issue>2</issue>
<elocation-id>572</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Xu et al.</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 16: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="16" page="179" id="RA1" xlink:href="10.3892/ol.2018.8636" ext-link-type="doi">179-188</related-article>, 2018; DOI: 10.3892/ol.2018.8636</p>
<p>Subsequently to the publication of this paper, it was drawn to the Editors&#x2019; attention by a concerned reader that the western blot data featured in Fig. 3F of the article were strikingly similar to data that had appeared in another article by different authors.</p>
<p>Owing to the fact that the contentious data in the above article had already appeared in another article prior to its submission to <italic>Oncology Letters</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors also requested either a corrigendum or a retraction of this paper on account of problems that has been identified with the antibodies used for the western blotting experiments. Upon consulting the authors, they agreed that the article should be retracted. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
